Rescula unoprostone isopropyl regulatory update

Japan granted Orphan Drug designation to unoprostone isopropyl from R-Tech Ueno to treat retinitis pigmentosa (RP). The docosanoid-type prostone is in Phase III testing for RP and is marketed as Rescu...